TELMISARTAN HCT AP 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan hct ap 80/25mg telmisartan 80mg and hydrochlorothiazide 25mg tablet blister pack

gm pharma international pty ltd - hydrochlorothiazide, quantity: 25 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: meglumine; sodium hydroxide; mannitol; povidone; magnesium stearate; lactose monohydrate; purified water; sodium stearylfumarate; colour - telmisartan hct ap is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

TELMISARTAN HCT AP 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan hct ap 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack

gm pharma international pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; sodium hydroxide; mannitol; meglumine; sodium stearylfumarate; purified water; iron oxide red - telmisartan hct ap is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

TELMISARTAN HCT AP 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan hct ap 40/12.5mg telmisartan 40mg and hydrochlorothiazide 12.5mg tablet blister pack

gm pharma international pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: sodium hydroxide; mannitol; povidone; lactose monohydrate; meglumine; magnesium stearate; sodium stearylfumarate; purified water; iron oxide red - telmisartan hct ap is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

METOPROLOL MKL metoprolol tartrate 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

metoprolol mkl metoprolol tartrate 100 mg tablet blister pack

gm pharma international pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; titanium dioxide; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; lactose monohydrate; macrogol 400; purified talc; croscarmellose sodium; hypromellose - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

METOPROLOL MKL metoprolol tartrate 50mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

metoprolol mkl metoprolol tartrate 50mg tablet blister pack

gm pharma international pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; iron oxide red; colloidal anhydrous silica; macrogol 400; croscarmellose sodium; hypromellose; magnesium stearate; titanium dioxide; lactose monohydrate; pregelatinised maize starch; purified talc - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

INDAPAMIDE CH indapamide hemihydrate 2.5mg sugar coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

indapamide ch indapamide hemihydrate 2.5mg sugar coated tablet blister pack

gm pharma international pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

Pranotach propranolol hydrochloride 40 mg tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

pranotach propranolol hydrochloride 40 mg tablet bottle pack

gm pharma international pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: lactose monohydrate; povidone; quinoline yellow; maize starch; brilliant blue fcf aluminium lake; sunset yellow fcf aluminium lake; magnesium stearate; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Pranotach propranolol hydrochloride 10 mg tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

pranotach propranolol hydrochloride 10 mg tablet bottle pack

gm pharma international pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: povidone; quinoline yellow; sodium starch glycollate; sunset yellow fcf aluminium lake; lactose monohydrate; magnesium stearate; maize starch - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

APOTEX-MEMANTINE memantine hydrochloride 20 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apotex-memantine memantine hydrochloride 20 mg film-coated tablet blister pack

gm pharma international pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide yellow; magnesium stearate; methylcellulose; titanium dioxide; hyprolose; iron oxide red; croscarmellose sodium; macrogol 8000; microcrystalline cellulose - treatment of the symptoms of moderately severe to severe alzheimer's disease (see pharmacology, precautions).

K-PROCHLORPERAZINE Australia - English - Department of Health (Therapeutic Goods Administration)

k-prochlorperazine

gm pharma international pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified water; colloidal anhydrous silica; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.